Tsvetelina Georgieva Batsalova

Dr. Tsvetelina Georgieva Batsalova

Plovdiv University, Plovdiv, Bulgaria
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
Sevdalina LambovaSevdalina Lambova
Sevdalina Lambova
Tsvetelina Georgieva BatsalovaTsvetelina Georgieva Batsalova
Tsvetelina Georgieva Batsalova
Dzhemal MotenDzhemal Moten
Dzhemal Moten
SSStela G. Stoyanova
Stela G. Stoyanova
EGElenka Georgieva
Elenka Georgieva
Balik DzhambazovBalik Dzhambazov
Balik Dzhambazov
Obesity is considered a major risk factor for the development and progression of knee osteoarthritis (OA). Apart from the mechanical effect of obesity via increase in mechanical overload of weight-bearing joints, an association with hand OA has been observed. There has been increasing interest in the role of adipokines in the pathogenesis of OA in the recent years. It has been suggested that their systemic effects link obesity and OA. In this regard, the aim of the current study was measurement and analysis of serum levels of leptin and resistin in patients with knee OA with different body mass index (BMI). Seventy-three patients with primary symptomatic knee OA at the age between 35 and 87 years (mean age 66 years) were included in the study (67 women and 6 men). The patients were from 2nd to 4th radiographic stage according to Kellgren–Lawrence scale. 43 patients were with concomitant obesity (BMI ≥ 30 kg/m2, mean values 38.34 ± 8.20) and 30 patients with BMI < 30 kg/m2 (mean values 25.07 ± 2.95). Eleven individuals with different BMIs, including cases with obesity but without radiographic knee OA, were examined as a control group. Serum levels of leptin and resistin were measured via ELISA method. In patients with knee OA and BMI ≥ 30 kg/m2, serum levels of leptin (39.546 ± 12.918 ng/mL) were significantly higher as compared with healthy individuals (15.832 ± 16.531 ng/mL, p < 0.05) and the patients with low BMI (p < 0.05). In patients with BMI < 30 kg/m2 the levels of leptin (13.010 ± 10.94 ng/mL) did not differ significantly from the respective values in the control group (p = 0.48). Serum levels of resistin were also higher in knee OA patients in comparison with healthy controls, but the difference was statistically significant only for patients with high BMI (2.452 ± 1.002 ng/mL in the group with BMI ≥ 30 kg/m2; 2.401 ± 1.441 ng/mL in patients with BMI < 30 kg/m2; 1.610 ± 1.001 ng/mL in the control group, p < 0.05). A correlation was found between the serum levels of leptin and radiographic stage of OA, i.e., higher leptin levels were present in the more advanced 3rd and 4th radiographic stage, while for resistin a correlation was observed in the patient subgroup with BMI < 30 kg/m2. Serum leptin and resistin levels and clinical characteristics were analyzed in patients with different clinical forms of OA. Novel clinical correlations have been found in the current study in patients with isolated knee OA vs. cases with presence of other disease localizations. It has been observed that patients with isolated knee OA were significantly younger and had higher BMI as compared with cases in whom OA is combined with other localizations i.e., spondyloarthritis ± presence of hip OA and with generalized OA. This supports the hypothesis that presence of obesity promotes earlier development of knee OA as an isolated localization of the disease in younger patients before appearance of osteoarthritic changes at other sites. The levels of leptin and resistin in isolated knee OA were also higher. Serum levels of leptin and resistin in combination with patients’ clinical characteristics suggest existence of different clinical and laboratory profile through which more precise definition of metabolic phenotype of knee OA would be possible. Considering the fact that obesity is a modifiable risk factor that has an impact on progression of knee OA, different approaches to influence obesity may offer potential for future disease-modifying therapeutic interventions.

1 December 2017 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
YGYordan Nikolaev Georgiev
Yordan Nikolaev Georgiev
MOManol Ognyanov
Manol Ognyanov
HKHiroaki Kiyohara
Hiroaki Kiyohara
Tsvetelina Georgieva BatsalovaTsvetelina Georgieva Batsalova
Tsvetelina Georgieva Batsalova
Balik DzhambazovBalik Dzhambazov
Balik Dzhambazov
MKMaria G. Kratchanova
Maria G. Kratchanova

1 November 2017 in Carbohydrate Polymers
Verified
Journal Article
Closed access
YGYordan Nikolaev Georgiev
Yordan Nikolaev Georgiev
BPBerit S. Paulsen
Berit S. Paulsen
HKHiroaki Kiyohara
Hiroaki Kiyohara
MCMilan Ciz
Milan Ciz
MOManol Ognyanov
Manol Ognyanov
MKMaria G. Kratchanova
Maria G. Kratchanova

Verified
Journal Article
Open access
PDF file
Tsvetelina Georgieva BatsalovaTsvetelina Georgieva Batsalova
Tsvetelina Georgieva Batsalova
YGYordan Nikolaev Georgiev
Yordan Nikolaev Georgiev
Dzhemal MotenDzhemal Moten
Dzhemal Moten
Ivanka TenevaIvanka Teneva
Ivanka Teneva
Balik DzhambazovBalik Dzhambazov
Balik Dzhambazov
It has been recently proven that xylooligosaccharides (XOS) with prebiotic properties have diverse beneficial biological effects including immunomodulatory and antitumor activities. The present article focused on the chemical and biological evaluation of corn-derived commercially available XOS and aimed to elucidate their cytotoxicity and inhibitory potential against tumor cells. Spectrophotometric chemical analyses, Fourier transform infrared spectroscopy, and high-performance liquid chromatography analyses were performed. Antioxidant activity was determined by measuring the oxygen radical absorbance capacity and hydroxyl radical averting capacity. In vitro cytotoxicity assays with human cell lines derived from normal and tumor tissues, assessments of ATP production, mitochondrial membrane potential specific staining, cytokine assays, and molecular docking were used to evaluate the biological activity of XOS. The sample showed significant antioxidant activity, and it was determined that most xylose oligomers in it are composed of six units. XOS exhibited antitumor activity with pronounced inhibitory effect on lysosomes, but mitochondrial functionality was also affected. The production of proinflammatory cytokines by lipopolysaccharide-stimulated U-937 cells was reduced by XOS treatment, which suggested the involvement of Toll-like receptor 4 (TLR4)-mediated signaling in the mechanism of XOS action. Molecular docking analyses confirmed the potential inhibitory interaction between the sample and TLR4. In addition, XOS treatment had significant tumor-cell-specific influence on the glutathione antioxidant system, affecting its balance and thus contributing to the inhibition of cellular viability. The present study elucidated the tumor-inhibitory potential of commercially available XOS that could be utilized in pharmaceutical and food industry providing disease-preventive and therapeutic benefits.

1 March 2011 in Fitoterapia
Verified
Journal Article
Closed access
AIAntoaneta Ivanova
Antoaneta Ivanova
BMBozhanka Mikhova
Bozhanka Mikhova
Tsvetelina Georgieva BatsalovaTsvetelina Georgieva Batsalova
Tsvetelina Georgieva Batsalova
Balik DzhambazovBalik Dzhambazov
Balik Dzhambazov
IKIvanka Kostova
Ivanka Kostova

29 June 2010 in Arthritis & Rheumatism
Verified
Journal Article
Open access
PDF file
Tsvetelina Georgieva BatsalovaTsvetelina Georgieva Batsalova
Tsvetelina Georgieva Batsalova
Balik DzhambazovBalik Dzhambazov
Balik Dzhambazov
PMPatrick Merky
Patrick Merky
ABAlexandra Bäcklund
Alexandra Bäcklund
JBJohan Bäcklund
Johan Bäcklund
Objective: To establish a new animal model in DRB1*0401 (DR4)–transgenic mice in which T cell tolerance to self type II collagen (CII) can be broken and allow for the development of autoimmune arthritis, to investigate the role of posttranslational modifications of the CII259–273 epitope in the induction and breaking of tolerance of DR4‐restricted T cells, and to characterize DR4‐restricted T cell recognition of the immunodominant CII259–273 epitope.Methods: DR4‐transgenic mice expressing either the entire human CII protein (HuCII) or only the immunodominant T cell epitope of heterologous CII (MMC) in joint cartilage were established on different genetic backgrounds, and susceptibility to collagen‐induced arthritis (CIA) was tested.Results: HuCII mice displayed stronger T cell tolerance to heterologous CII than did MMC mice. On the B10 background, arthritis developed only in MMC mice with a defective oxidative burst. However, MMC mice on the C3H background were susceptible to arthritis also with a functional oxidative burst. Significant recall responses in tolerized mice were detected only against the nonglycosylated CII259–273 epitope. Recognition of the CII259–273 epitope was heterogeneous, but the majority of T cells in DR4 mice specifically recognized the nonglycosylated side chain of lysine at position 264.Conclusion: It is possible to break tolerance to self CII and induce arthritis in DR4 mice. However, arthritis susceptibility is tightly controlled by the genetic background and by the source of the transgenic element for expressing the heterologous CII peptide as a self CII protein in the joint. In contrast to CIA in Aq‐expressing mice, the nonglycosylated CII259–273 epitope is clearly immunodominant in both tolerized and nontolerized DR4 mice.